Dundas Partners LLP

SEC CIK: 0001742418
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

ABT holding history

Abbott Laboratories in every 13F filed by Dundas Partners LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overview All 13F holders of ABT Full Q2 2026 holdings

Shares (Q2 2026): 423,933
Value: $38.5M
% of portfolio: 2.8%
Quarters held: 22; Since Q1 2021

Holdings of ABT by Dundas Partners LLP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	423,933	$38.5M	2.8%	00.0%	Unchanged	Holders
Q1 2026	423,933	$43.5M	3.5%	−4,374−1.0%	Reduced	Holders
Q4 2025	428,307	$53.7M	3.8%	−14,647−3.3%	Reduced	Holders
Q3 2025	442,954	$59.3M	4.2%	+71,239+19.2%	Added	Holders
Q2 2025	371,715	$50.6M	3.5%	+26,666+7.7%	Added	Holders
Q1 2025	345,049	$45.8M	3.4%	00.0%	Unchanged	Holders
Q4 2024	345,049	$39.0M	2.7%	00.0%	Unchanged	Holders
Q3 2024	345,049	$39.3M	2.8%	+14,822+4.5%	Added	Holders
Q2 2024	330,227	$34.3M	2.7%	+6,897+2.1%	Added	Holders
Q1 2024	323,330	$36.8M	2.9%	00.0%	Unchanged	Holders
Q4 2023	323,330	$35.6M	3.1%	00.0%	Unchanged	Holders
Q3 2023	323,330	$31.3M	3.1%	+35,740+12.4%	Added	Holders
Q2 2023	287,590	$31.4M	3.0%	00.0%	Unchanged	Holders
Q1 2023	287,590	$29.1M	3.0%	−1,346−0.5%	Reduced	Holders
Q4 2022	288,936	$31.7M	3.4%	+4,700+1.7%	Added	Holders
Q3 2022	284,236	$27.5M	3.2%	00.0%	Unchanged	Holders
Q2 2022	284,236	$30.9M	3.3%	00.0%	Unchanged	Holders
Q1 2022	284,236	$33.6M	3.1%	+59,653+26.6%	Added	Holders
Q4 2021	224,583	$28.4M	3.5%	+16,036+7.7%	Added	Holders
Q3 2021	208,547	$24.6M	3.5%	00.0%	Unchanged	Holders
Q2 2021	208,547	$24.2M	3.5%	00.0%	Unchanged	Holders
Q1 2021	208,547	$25.0M	4.0%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.